Workflow
Immunocore Holdings (IMCR) 2025 Conference Transcript
IMCRImmunocore(IMCR)2025-06-06 00:05

Immunocore Holdings (IMCR) 2025 Conference June 05, 2025 11:05 AM ET Speaker0 Welcome everyone to the next session. I'm Michael Yee, Senior Biotechnology Analyst at Jefferies and I'm Speaker1 very pleased to have members of the Immunocor team up here with us. David Berman, Chief Scientific Officer and Ralph Torbay, the Chief Commercial Officer. Fantastic duo bunch because we're going to talk about revenues and sales and an approved drug in the commercial side. And, we're also going to Speaker0 talk with Dav ...